These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28355061)

  • 1. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.
    Neves AR; Queiroz JF; Lima SAC; Reis S
    Bioconjug Chem; 2017 Apr; 28(4):995-1004. PubMed ID: 28355061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.
    Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G
    J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E.
    Neves AR; Queiroz JF; Weksler B; Romero IA; Couraud PO; Reis S
    Nanotechnology; 2015 Dec; 26(49):495103. PubMed ID: 26574295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.
    Neves AR; Queiroz JF; Reis S
    J Nanobiotechnology; 2016 Apr; 14():27. PubMed ID: 27061902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
    Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
    J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
    Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
    Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
    Kuo YC; Shih-Huang CY
    J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
    Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
    Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
    Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
    Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.
    Shah RM; Rajasekaran D; Ludford-Menting M; Eldridge DS; Palombo EA; Harding IH
    Colloids Surf B Biointerfaces; 2016 Apr; 140():204-212. PubMed ID: 26764103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease.
    Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
    Eur J Pharm Sci; 2020 May; 148():105314. PubMed ID: 32200044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
    Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.
    Martins S; Costa-Lima S; Carneiro T; Cordeiro-da-Silva A; Souto EB; Ferreira DC
    Int J Pharm; 2012 Jul; 430(1-2):216-27. PubMed ID: 22465548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB.
    Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N
    Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-functionalized lipid nanoparticles for curcumin brain delivery.
    Neves AR; van der Putten L; Queiroz JF; Pinheiro M; Reis S
    J Biotechnol; 2021 Apr; 331():108-117. PubMed ID: 33727082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line.
    Chattopadhyay N; Zastre J; Wong HL; Wu XY; Bendayan R
    Pharm Res; 2008 Oct; 25(10):2262-71. PubMed ID: 18516666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of solid lipid nanoparticles for sustained drug release.
    Attama AA; Umeyor CE
    Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.